Additionally, Biodeals offerings span various dosage formats, including dry powder inhalation capsules, capsules, tablets, ointments, lotions, and dusting powder.The strong market potential of the nasal sprays segment, along with the Biodeals leading position in contract manufacturing and adherence to global regulatory standards, presents an exciting opportunity for us," said Kalpesh Kikani, CEO, Piramal Alternatives. "With a renewed focus on innovation and efficiency and USFDA compliance infrastructure, Biodeal is poised to introduce novel solutions that address unmet medical needs and enhance patient outcomes with the unique drug delivery system as Nasal Sprays (nasal root of administration) across geographies and regulatory regimes, he added.Biodeal has revenue of Rs 101 crore in FY23 and serves all top Indian pharmaceutical companies.Emkay Global was the exclusive financial advisor to Biodeal for this deal. It is among Indias leading manufacturers of nasal sprays catering to marquee international and domestic pharmaceutical companies.Earlier this year, the company attained itsPharmaceutical Inspection Co-operation Scheme (PIC/S) approval. Additionally, Biodeals offerings span various dosage formats, including dry powder inhalation capsules, capsules, tablets, ointments, lotions, and dusting powder.The strong market potential of the nasal sprays segment, along with the Biodeals leading position in contract manufacturing and adherence to global regulatory standards, presents an exciting opportunity for us," said Kalpesh Kikani, CEO, Piramal Alternatives. "With a renewed focus on innovation and efficiency and USFDA compliance infrastructure, Biodeal is poised to introduce novel solutions that address unmet medical needs and enhance patient outcomes with the unique drug delivery system as Nasal Sprays (nasal root of administration) across geographies and regulatory regimes, he added.Biodeal has revenue of Rs 101 crore in FY23 and serves all top Indian pharmaceutical companies.Emkay Global was the exclusive financial advisor to Biodeal for this deal.